Technical Analysis for BVXP - Bioventix Plc

Grade Last Price % Change Price Change
F 4065.0 0.87% 35.00
BVXP closed up 0.87 percent on Friday, April 16, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat
Historical BVXP trend table...

Date Alert Name Type % Chg
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness 0.87%
Oversold Stochastic Weakness 0.87%
NR7 Range Contraction 0.87%
NR7-2 Range Contraction 0.87%
Lower Bollinger Band Walk Weakness 0.87%
Stochastic Reached Oversold Weakness 0.87%
Lower Bollinger Band Touch Weakness 0.87%
Oversold Stochastic Weakness 0.87%
Pocket Pivot Bullish Swing Setup -0.37%
Older End-of-Day Signals for BVXP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Previous Day's Low 5 days ago
Down 3% 5 days ago
Down 2% 5 days ago
Down 1% 5 days ago
Lower Bollinger Band Support 5 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Bioventix Plc Description

Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing. The Company's non-vitamin D business consists of antibodies, NT proBNP (heart failure), testosterone, Free Triiodothyronine (FT3) (thyroid hormone), estradiol, and various drugs, such as tetrahydrocannabinol (THC)/cannabis, and progesterone. The Company offers products for indications, such as thyroid, fertility, oncology, cardiac, vitamin D, drug of abuse, infectious disease and miscellaneous. Its sheep hybridoma technology produces cell lines that secrete SMAs. The Company offers a panel of SMAs to 25-OH D and has various 25-OH D2 and 25-OH D3 specific antibodies. It sells its products through direct sales and through distributors.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Clinic Disease Radio Testing Branches Of Biology Medical Specialties Oncology Drugs Offers Products Immunology E Testing Antibody Immune System Infectious Infectious Disease Antibodies Glycoproteins Heart Failure Organ Systems Monoclonal Antibodies Thyroid Monoclonal Testosterone

Is BVXP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 4549.2349
52 Week Low 3800.0
Average Volume 2,805
200-Day Moving Average 4183.66
50-Day Moving Average 4242.20
20-Day Moving Average 4157.75
10-Day Moving Average 4084.50
Average True Range 143.26
ADX 21.55
+DI 7.84
-DI 14.64
Chandelier Exit (Long, 3 ATRs ) 3970.21
Chandelier Exit (Short, 3 ATRs ) 4429.79
Upper Bollinger Band 4335.70
Lower Bollinger Band 3979.80
Percent B (%b) 0.24
BandWidth 8.56
MACD Line -59.20
MACD Signal Line -50.00
MACD Histogram -9.1968
Fundamentals Value
Market Cap 211.76 Million
Num Shares 5.21 Million
EPS 137.90
Price-to-Earnings (P/E) Ratio 29.48
Price-to-Sales 20.25
Price-to-Book 16.64
Dividend 0.88
Dividend Yield 0.02%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4215.00
Resistance 3 (R3) 4210.00 4155.00 4190.00
Resistance 2 (R2) 4155.00 4116.80 4157.50 4181.66
Resistance 1 (R1) 4110.00 4093.20 4132.50 4115.00 4173.33
Pivot Point 4055.00 4055.00 4066.25 4057.50 4055.00
Support 1 (S1) 4010.00 4016.80 4032.50 4015.00 3956.67
Support 2 (S2) 3955.00 3993.20 3957.50 3948.34
Support 3 (S3) 3910.00 3955.00 3940.00
Support 4 (S4) 3915.00